Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
Indiana University
Indiana University
Fred Hutchinson Cancer Center
City of Hope Medical Center
Roswell Park Cancer Institute
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Stanford University
Massachusetts General Hospital
Mayo Clinic
University of Alabama at Birmingham
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Massachusetts General Hospital
Massachusetts General Hospital
University of Virginia
M.D. Anderson Cancer Center
Fox Chase Cancer Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of California, Davis
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
University of Wisconsin, Madison
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Washington
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
University of Louisville
Dana-Farber Cancer Institute
Yale University
Alliance for Clinical Trials in Oncology
Indiana University
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins